Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Conmed expands portfolio with Bard's endoscopic line

This article was originally published in Clinica

Executive Summary

Conmed is to acquire from CR Bard certain products from its Endoscopic Technologies business, including its line of single-use medical devices used to diagnose and treat diseases of the digestive tract and lungs. The transaction will cost Conmed $80m in total, of which $30m will be an up-front cash payment and the rest in borrowings under its revolving line of credit.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT059433

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel